ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 226 filers reported holding ROIVANT SCIENCES LTD in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $109,695 | -96.0% | 10,378 | -96.1% | 0.00% | -97.0% |
| Q1 2024 | $2,772,526 | +2452.9% | 263,048 | +2620.0% | 0.07% | +6600.0% |
| Q4 2023 | $108,605 | -24.6% | 9,671 | -21.6% | 0.00% | -80.0% |
| Q3 2023 | $144,026 | +25.7% | 12,331 | +8.5% | 0.01% | +25.0% |
| Q2 2023 | $114,599 | +106010.2% | 11,369 | -22.5% | 0.00% | +33.3% |
| Q1 2023 | $108 | +500.0% | 14,675 | +532.0% | 0.00% | +200.0% |
| Q4 2022 | $18 | -99.9% | 2,322 | -56.8% | 0.00% | – |
| Q3 2022 | $17,000 | -82.1% | 5,376 | -77.1% | 0.00% | -100.0% |
| Q2 2022 | $95,000 | +239.3% | 23,499 | +307.8% | 0.00% | – |
| Q1 2022 | $28,000 | +300.0% | 5,762 | +789.2% | 0.00% | – |
| Q4 2021 | $7,000 | – | 648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 66,719,779 | $705,228,064 | 66.32% |
| Patient Square Capital LP | 12,228,465 | $129,254,875 | 59.99% |
| Atalaya Capital Management LP | 1,714,843 | $18,125,891 | 40.31% |
| Two Seas Capital LP | 10,318,764 | $109,069,335 | 17.73% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $51,081,026 | 15.77% |
| Whitefort Capital Management, LP | 2,391,000 | $25,272,870 | 15.58% |
| STEMPOINT CAPITAL LP | 2,712,741 | $28,673,672 | 8.43% |
| Tejara Capital Ltd | 2,183,943 | $23,084,278 | 8.39% |
| Tyro Capital Management LLC | 1,744,327 | $18,437,536 | 8.36% |
| ADAR1 Capital Management, LLC | 4,150,009 | $43,865,595 | 8.28% |